WAYNE, Pa., June 11, 2015 /PRNewswire/ -- Ryan &
Maniskas, LLP is investigating potential claims against the board
of directors of DARA BioSciences, Inc. ("DARA" or the "Company")
(NASDAQ: DARA) concerning possible breaches of fiduciary duty and
other violations of law related to the Company's efforts to sell
the Company to Midatech Pharma PLC ("Midatech").
If you own shares of DARA and would like to learn more about
this class action or if you wish to discuss these matters and have
any questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire
toll-free at (877) 316-3218 or to sign up online, visit:
www.rmclasslaw.com/cases/dara. You may also email Mr.
Maniskas at rmaniskas@rmclasslaw.com.
Under the terms of the agreement, shareholders of DARA will
receive (i) 0.272 Ordinary Shares of Midatech, subject to certain
adjustments described in more detail below, and (ii) one Contingent
Value Right ("CVR"). All Midatech Ordinary Shares will be
delivered to the holders of DARA Common Stock in the form of
American Depositary Receipts ("ADRs").
Our investigation concerns possible breaches of fiduciary duty
and other violations of state law by the Board of Directors of DARA
for not acting in the Company's shareholders' best interests in
connection with the sale process.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide. To learn more
about the class action process, please visit:
www.rmclasslaw.com.
CONTACT: Ryan & Maniskas,
LLP
Richard A. Maniskas,
Esquire
995 Old Eagle School Rd., Suite
311
Wayne, PA
19087
877-316-3218
www.rmclasslaw.com/cases/dara
rmaniskas@rmclasslaw.com
Logo -
http://photos.prnewswire.com/prnh/20121112/MM11729LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ryan--maniskas-llp-investigation-of-dara-biosciences-inc-300097797.html
SOURCE Ryan & Maniskas, LLP